Biopolym. Cell. 2010; 26(2):128-135.
http://dx.doi.org/10.7124/bc.00014F
Molecular Biomedicine
Vitamin, mineral and iron supplementation in pregnancy: cross-sectional study
1Leppee M., 1, 2Culig J., 3Eric M., 4Boskovic J., 5Colak N.
  1. Andrija Stampar Institute of Public Health
    16, Mirogojska, Zagreb, Croatia, 10000
  2. School of Medicine
    Josip Juraj Strossmayer University of Osijek
    4, Huttlerova, Osijek, Croatia, 31000
  3. School of Medicine,
    University of Novi Sad
    3, Hajduk Veljkova, Novi Sad, Serbia, 21000
  4. Faculty of Pharmacy and Biochemistry
    1 A. Kovacica, Zagreb, Croatia, 10000
  5. Colpharm d. o. o.
    16, Trnska cesta, Siroki Brijeg, Bosnia and Herzegovina, 88220

Abstract

Aim. To assess the use of vitamin, mineral and iron supplements during pregnancy in Zagreb and Novi Sad. Methods. The study was conducted by use of a structured standardized questionnaire consisting of two parts, i. e. data obtained by maternal interview and hospital records. It is designed as a cross-sectional study in two countries (Croatia and Serbia). The study included 893 pregnant women from Zagreb and 6099 pregnant women from Novi Sad. Results. In Zagreb, pregnant women reported highest utilization of vitamin-mineral supplements (n = 508; 56.9 %), whereas in Novi Sad these supplements ranked third (n = 408; 20.3 %), following tocolytics and iron supplements. There was no statistically significant difference in the prevalence of congenital malformations between neonates at in utero exposure to vitamins, minerals and iron supplements and those without such exposure in either Zagreb or Novi Sad arm, with the exception of iron and calcium supplementation in the Zagreb arm. Conclusions. In spite of certain study limitations, the results obtained pointed to the unreasonable and potentially harmful use of these supplements in pregnant women from Zagreb.
Keywords: vitamins, minerals, pregnancy, Zagreb, Novi Sad
Full text: (PDF, in English)

References

[1] Jackson A. A., Robinson S. M. Dietary guidelines for pregnancy: a review of current evidence Publ. Health Nutr 2001 4, N 2B P. 625–630.
[2] Kind K. L., Moore V. M., Davies M. J. Diet around conception and during pregnancy – effects on fetal and neonatal outcomes Repr. Biomed. Online 2006 12, N 5 P. 532–541.
[3] Glenville M. Nutritional supplements in pregnancy: commercial push or evidence based? Curr. Opin. Obstet. Gynecol 2006 18, N 6 P. 642–647.
[4] Collaborative Group on Drug Use in Pregnancy (CGDUP). Medication during pregnancy: an intercontinental cooperative study Int. J. Gynecol. Obstet 1992 39, N 3 P. 185–196.
[5] Bonati M., Bortolus R., Marchetti F., Romero M., Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies Eur. J. Clin. Pharmacol 1990 38, N 4 P. 325–328.
[6] Lacroix I., Damase-Michel C., Lapeyre-Mestre M., Montastruc J. L. Prescription of drugs during pregnancy in France Lancet 2000 356, N 9243 P. 1735–1736.
[7] Beyens M. N., Guy C., Ratrema M., Ollagnier M. Prescription of drugs to pregnant women in France: the HIMAGE study Therapie 2003 58, N 6 P. 505–511.
[8] Shah M. D., Shah S. R. Nutrient deficiencies in the premature infant Pediatr. Clin. North Am 2009 56, N 5 P. 1069– 1083.
[9] Leppee M. Drugs in pregnancy. PhD thesis. School of Medicine, Josip Juraj Strossmayer University Osijek, 2008.
[10] Egen-Lappe V., Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population Eur. J. Clin. Pharmacol 2004 60, N 9 P. 659–666.
[11] Piper J. M., Baum C., Kennedy D. L. Prescription drug use before and during pregnancy in a Medicaid population Am. J. Obstet. Gynecol 1987 157, N 1 P. 148–156.
[12] Kebede B., Gedif T., Getachew A. Assessment of drug use among pregnant women in Addis Ababa, Ethiopia Pharmacoepidemiol. Drug Saf 2009 18, N 6 P. 462–468.
[13] Das B., Sarkar C., Datta A., Bohra S. A study of drug use during pregnancy in a teaching hospital in western Nepal Pharmacoepidemiol. Drug Saf 2003 12, N 3 P. 221–225.
[14] Mills J. L., Simpson J. L., Cunningham G. C., Conley M. R., Rhoads G. G. Vitamin A and birth defects Am. J. Obstet. Gynecol 1997 177, N 1 P. 31–36.
[15] Rothman K. J., Moore L. L., Singer M. R., Nguyen U. S., Mannino S., Milunsky A. Teratogenicity of high vitamin A intake N. Engl. J. Med 1995 333, N 21 P. 1369–1373.
[16] Javaid M. K., Crozier S. R., Harvey N. C., Gale C. R., Dennison E. M., Boucher B. J., Arden N. K., Godfrey K. M., Cooper C. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study Lancet 2006 367, N 9504 P. 36–43.
[17] Devereux G., Turner S. W., Craig L. C., McNeill G., Martindale S., Harbour P. J., Helms P. J., Seaton A. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children Am. J. Respir. Crit. Care Med 2006 174, N 5 P. 499–507.
[18] Briggs G. G., Freeman R. K., Yaffe S. J. Drugs in pregnancy and lactation: 5th ed Baltimore: Williams and Wilkins, 1998 1219 p.
[19] Huskisson E., Maggini S., Ruf M. The role of vitamins and minerals in energy metabolism and well-being J. Int. Med. Res 2007 35, N 3 P. 277–289.
[20] Seligman P. A. Measurment of iron absorption from prenatal multivitamin-mineral supplements Obstet. Gynecol. 1983; 61, N 3 P. 356.
[21] De Jong-van den Berg L. T., Van den Berg P. B., HaaijerRuskamp F. M., Dukes M. N., Wesseling H. Investigating drug use in pregnancy. Methodological problems and perspectives Pharm. Weekbl. (Sci.) 1991 13, N 1 P. 32–38.